장마감
로그인 회원가입
NOVT
NOVT
Novanta Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$140.80
-0.74 ▼ -0.52%
🌙 7월 27일 7:05 PM ET (한국 7/28 08:05)
$140.80
+0.00 +0.00%

노바타(NOVT) is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$5.0B
스몰캡
P/E
101.7
고평가 구간
배당수익률
없음
52주 위치
58%
저점 +43% · 고점 -18%
애널리스트
매수
B-
Fundamental health
vs. Scientific & Technical Instruments
수익성 ⓘ
Top 50%
성장 ⓘ
Top 54%
밸류에이션 ⓘ
Top 29%
재무 안정 ⓘ
Top 41%
💰 Is this stock pricier than usual right now? ⓘ
Compared to this company's own recent 5년 (not other companies).
Very cheap
Cheap
Typical
Pricey
Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 94원. Over the past 5년, it usually traded around 81원. On the pricier side versus its own history.
Pricy doesn't mean bad — it means expectations are already baked in.
Index ⓘ RUTP/E ⓘ 101.7EPS (ttm) ⓘ 1.38Insider Own ⓘ 0.75%Shs Outstand ⓘ 35.6MPerf Week ⓘ -1.92%
Market Cap ⓘ 5.01BForward P/E ⓘ 33.98EPS next Y ⓘ 15.41%Insider Trans ⓘ -17.18%Shs Float ⓘ 35.3MPerf Month ⓘ -12.24%
Enterprise Value ⓘ 4.92BPEG ⓘ -EPS next Q ⓘ 0.83Inst Own ⓘ 115.45%Short Float ⓘ 14.97%Perf Quarter ⓘ 5%
Income ⓘ 0.05BP/S ⓘ 4.99EPS this Y ⓘ 9.12%Inst Trans ⓘ 3.55%Short Ratio ⓘ 9.93Perf Half Y ⓘ 2.11%
Sales ⓘ 1.00BP/B ⓘ 3.82EPS next 5Y ⓘ -ROA ⓘ 3.37%Short Interest ⓘ 5.29MPerf YTD ⓘ 18.33%
Book/sh ⓘ 36.82P/C ⓘ 12.9EPS past 3/5Y ⓘ -10.74% 2.97%ROE ⓘ 5.16%52W High ⓘ -18.07% ($171.85)Perf Year ⓘ 10.68%
Cash/sh ⓘ 10.92P/FCF ⓘ 74.49Sales past 3/5Y ⓘ 4.43% 10.67%ROIC ⓘ 3.46%52W Low ⓘ 43.28% ($98.27)Perf 3Y ⓘ -19.7%
Dividend Est. ⓘ -EV/EBITDA ⓘ 27.41EPS Y/Y TTM ⓘ -28.67%Gross Margin ⓘ 41.48%Volatility(W/M) ⓘ 4.16% 4.91%Perf 5Y ⓘ 6.73%
Dividend TTM ⓘ -EV/Sales ⓘ 4.89Sales Y/Y TTM ⓘ 5.59%Oper. Margin ⓘ 11.63%ATR (14) ⓘ 7.23Perf 10Y ⓘ 788.33%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 2.69EPS Q/Q ⓘ -12.67%Profit Margin ⓘ 5.35%RSI (14) ⓘ 38.57Recom ⓘ 2
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 3.56Sales Q/Q ⓘ 10.43%SMA20 ⓘ -6.66% ($150.85)Beta ⓘ 1.69Target Price ⓘ $175
Payout ⓘ -Debt/Eq ⓘ 0.22Earnings ⓘ 2026/8/5SMA50 ⓘ -9.21% ($155.08)Rel Volume ⓘ 0.55Prev Close ⓘ $141.54
Employees ⓘ 3000LT Debt/Eq ⓘ 0.18EPS/Sales Surpr. ⓘ 4.29% 1.7%SMA200 ⓘ 6.5% ($132.21)Avg Volume(3M) ⓘ 0.53MPrice ⓘ $140.8
IPO ⓘ 1995/9/22Option/Short ⓘ Yes/YesTrades ⓘ 8012Volume ⓘ 290,800Change ⓘ -0.52%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12*
25.3
25.6
25.9
25.12*
26.4
Revenue Net income 최근 분기: 매출 $258M (YoY +10%) · 순이익 $21M (YoY -1%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Novanta Inc (NOVT) Investment Analysis

What kind of company is Novanta Inc?

노바타(NOVT)
Technology · Scientific & Technical Instruments
#1396 by Market Cap — Mid-Cap

🔬 This U.S. technology company supplies precision optics, vision, and motion components used in medical and advanced industrial equipment. It provides precision components such as laser and optical scanning systems, precision motion control, and machine vision to medical and industrial equipment manufacturers, making it a precision instruments play whose results are tied to medical and automation demand, new orders, and acquisitions.

Learn more about Novanta Inc →
Market Cap
$5.0B
Approx. KRW 6.9 trillion
⚖️ 2% of Samsung Electronics
Market Cap Rank1396
Employees3,000people
IPO1995/09/22
Current Price$140.80 ≈ 192,896원
📌 RUT · NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release D-9
8월 5일 (수) · 장 마감 후
예상 매출 - · EPS $0.83
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 5월 11일 (월) · 장 마감 후 EPS +4.3% 매출 +1.7%
🔔 Earnings release 2026년 2월 23일 (월) · 장 마감 후 EPS +3.4% 매출 +1.1%

Is it profitable?

Financial health solid
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
11.6%
✓ 양호
My positionMid-range
Low range Average High range
Scientific & Technical Instruments Median 10.4% · Top 46%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
5.3%
✓ 양호
My positionMid-range
Low range Average High range
Scientific & Technical Instruments Median 3.1% · Top 44%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
41.5%
✓ 양호
My positionMid-range
Low range Average High range
Scientific & Technical Instruments Median 41.3% · Top 50%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
5.2%
✓ 평균
My positionMid-range
Low range Average High range
Technology 중형주 Median 9.5% · Bottom 42%
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
3.4%
✓ 평균
My positionMid-range
Low range Average High range
Technology 중형주 Median 3.6% · Bottom 49%
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
3.5%
✓ 평균
My positionMid-range
Low range Average High range
Technology 중형주 Median 5.3% · Bottom 45%
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.22
✓ Healthy debt
My positionMid-range
Low range Average High range
Scientific & Technical Instruments Median 0.20
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
3.56
✓ 양호
My positionMid-range
Low range Average High range
Scientific & Technical Instruments Median 2.38
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
2.69
✓ 양호
My positionMid-range
Low range Average High range
Scientific & Technical Instruments Median 1.92
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook
Price targets, growth, and valuation are favorable
애널리스트 목표가
$175.00
현재가 대비 +24.3%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
33.98배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
내년 EPS 예상 성장률
+15.4%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Reliability
Beat estimates in 2 of the last 2 quarters
2
예상 상회
0
예상 부합
0
예상 하회
100%
상회 비율
+3.9%
평균 서프라이즈
2026.05.11
상회
실적 $0.81 · 예상 $0.78 +4.3%
2026.02.23
상회
실적 $0.91 · 예상 $0.88 +3.4%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Average Growth
Mid-range within the industry
Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+9.1%
양호
My positionMid-range
Low range Average High range
미분류 중형주 Median 7.3% · Top 49%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+15.4%
평균
My positionMid-range
Low range Average High range
미분류 중형주 Median 15.6% · Bottom 50%
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
-10.7%
평균
My positionMid-range
Low range Average High range
미분류 중형주 Median 18.2% · Bottom 28%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+3.0%
평균
My positionMid-range
Low range Average High range
미분류 중형주 Median 6.4% · Bottom 45%
Past 5-Year Revenue
How much revenue grew over the past 5 years
+10.7%
양호
My positionMid-range
Low range Average High range
미분류 중형주 Median 9.8% · Top 47%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+10.4%
평균
My positionMid-range
Low range Average High range
미분류 중형주 Median 10.8% · Bottom 49%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -62%p below the market
NOVT +6.7% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-61.6%p
Significantly behind the market
vs Technology (XLK)
-121.1%p
Significantly behind the sector average
1-year basis
vs S&P 500
-5.3%p
slightly behind the market
vs Technology (XLK)
-22.4%p
behind the sector average
Current position within 52-week range
Low (-43.3%p) High (-18.1%p)
Current price is 43.3% above the 52-week low and 18.1% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-22.7%
Annualized volatility
49.3%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 137-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-27
Downtrend zone

Current price $140.80 below the midline ($150.84). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-27
Bearish momentum holding

MACD -3.502 < Signal -2.374 in negative zone + Hist negative (-1.128). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 38.6 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 8.0.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average
Cheap on Vs. Sales, Pricey on Vs. Earnings·Vs. Cash Flow, In line with peers on Vs. Assets
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Pricey
🏢 Vs. Assets Mid-range
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Pricey
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
101.70x
✓ Pricey
My positionBottom 25%
Low range Average High range
Scientific & Technical Instruments median 46.05x · Bottom 23% — expensive within the industry
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
33.98x
✓ Pricey
My positionBottom 25%
Low range Average High range
Scientific & Technical Instruments median 22.34x · Bottom 25% — expensive within the industry
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
3.82x
✓ Fair
My positionMid-range
Low range Average High range
Scientific & Technical Instruments median 3.29x · Around the industry average
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
4.99x
✓ Cheap
My positionMid-range
Low range Average High range
Scientific & Technical Instruments median 5.02x · Around the industry average
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
27.41x
✓ Fair
My positionMid-range
Low range Average High range
Scientific & Technical Instruments median 20.46x · Around the industry average
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
74.49x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Scientific & Technical Instruments median 26.58x · Bottom 1% — expensive within the industry
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$175.00 vs. current price +24.3%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Scientific & Technical Instruments

Who owns it?

Ownership flow shows some pressure
Insider net selling -17.2% · Institutional net buying +3.5% · Short interest elevated 15.0% · Short interest up +4.9pp over last 90d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-17.2%
Insiders large net selling
🏦 Institutions (funds & investors)
+3.5%
Institutions net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 115.5%
Institution-led, stable structure
Technology 중형주 Median 87.1%
🧑‍💼 Insiders 0.8%
Low, common among large-caps
Technology 중형주 Median 5.1%
👤 Retail investors (estimated) 0.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
15.0%
Somewhat high
Technology 중형주 Median 10.2%
Past 90 days 📈 +4.9%p increase
Short interest days to cover
9.9 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 35.6M주
Float (tradable shares) 35.3M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding NOVT

ETFs with the highest weightings · 10 total shown
KNOW
KNOW
Fundamentals First ETF
2.95%
$7M
BOUT
BOUT
CapForce IBD Breakout Opportunities ETF
2.95%
$16M
CSMD
CSMD
Congress SMid Growth ETF
2.38%
$467M
KOID
KOID
KraneShares Global Humanoid Robotics and Physical AI Index ETF
2.05%
$286M
HTEC
HTEC
ROBO Global Healthcare Technology and Innovation ETF
1.67%
$74M
* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
NOVT NOVT This Stock
$5.0B101.7 ▼3.8 ▼5.16% ▲- -0.5%
AAPL
$4.95T40.8 ▼46.4 ▼141.47% ▲0.32% ▼+1.2%
NVDA
$4.76T30.1 ▲24.4 ▼114.29% ▲0.33% ▼-5.0%
MSFT
$2.89T23.2 ▲7.0 ▼34.01% ▲0.95% ▼+1.9%
TSM
$2.07T28.8 ▲11.2 ▼40.06% ▲1.03% ▼-1.1%
AVGO
$1.82T63.8 ▼20.8 ▼37.28% ▲0.68% ▼+0.4%
Sector Avg-31.13.01.77%1.11%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen
→

Related News & Content

📖 Company overview
노반타(NOVT) 뭐하는 회사일까? - 주가 전망·실적·시총·관련주·본사 총정리
노반타(NOVT)는 의료·첨단 산업 장비용 정밀 광학·비전·모션 부품을 공급하는 미국 기업으로, 의료·자동화 수요와 신규 수주, 인수 확장과 마진에 실적과 주가가 연동되며, 장비에 통합된 고부가 부품과 높은 마진이 특징인 정밀 기기 종목입니다.
📚 Related Investment Guides
반도체 ETF 비교 — SOXX vs SOXQ vs SMH, 뭘 사야 할까?
반도체 ETF SOXX vs SOXQ vs SMH 완벽 비교. SOXQ는 SOXX와 같은 종목인데 보수가 절반. 초보자를 위한 반도체 ETF 선택 가이드.
미국주식 세금 총정리 2026 — 초보자를 위한 계산법과 절세 전략
2026년 미국주식 세금 총정리. 양도소득세 22% 계산법, 배당세 15% 원천징수, 손익통산, 절세 전략까지. 실제 금액 시뮬레이션과 세금 계산기로 내 세금을 직접 확인해보세요.

FAQ

What kind of company is 노바타(NOVT)?

노바타(NOVT) belongs to the Technology sector and operates in the Scientific & Technical Instruments industry.

What is the market cap of NOVT?

The market cap of NOVT is approximately $5.0B, ranking 1,396 within its sector.

What is the P/E ratio of NOVT?

NOVT has a P/E ratio of approximately 101.7x, which can be used to assess its valuation relative to the Technology sector average.

What is the 52-week high and low for NOVT?

NOVT has recorded a 52-week high of $171.85 and a low of $98.27.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.